Houston, TXNCT06312722Now EnrollingIRB Ready

Benign Prostatic Hyperplasia Clinical Trial in Houston, TX

Access cutting-edge benign prostatic hyperplasia treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by Urotronic Inc.

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access benign prostatic hyperplasia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related benign prostatic hyperplasia treatment provided free

Apply for This Houston Location

Check if you qualify for this benign prostatic hyperplasia clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Benign Prostatic Hyperplasia Study in Houston

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

Sponsor: Urotronic Inc.

Who Can Participate

Inclusion Criteria

Male subject ≥ 50 years old
Diagnosed with lower urinary tract symptoms (LUTS) secondary to obstructive benign prostatic hyperplasia (BPH)
Able to be treated with the Optilume BPH Catheter System in accordance with the Instructions for Use
Prostate volume \< 80 g with a prostatic urethral length between 32-55 mm as determined by trans-rectal ultrasound (TRUS)
International Prostate Symptom Score (IPSS) ≥ 13
Peak urinary flow rate (Qmax) 5-15 mL/sec with minimum voided volume of 125 mL
Willing to provide informed consent and comply with protocol required follow-up

Exclusion Criteria

Unwilling to abstain from sexual intercourse or use a condom for 30 days post-procedure and utilize a highly effective contraceptive for at least 12 months post-procedure
Presence of an artificial urinary sphincter, penile prosthesis, or stent(s) in the urethra or prostate
Any prior minimally invasive intervention (e.g., TUNA, Balloon, Microwave, Rezūm, UroLift) or surgical intervention of the prostate
Confirmed or suspected malignancy of prostate or bladder. Negative prostate biopsy required within 6 months of enrollment if PSA at baseline is \> 4 ng/mL with free PSA \< 25%.
Active urinary tract infection (UTI) confirmed by culture
Neurogenic bladder or sphincter abnormalities or neurological disorders that might affect bladder or sphincter function
History of overt urinary incontinence requiring the use of pads
Previous or current diagnosis of urethral strictures, bladder neck contracture or detrusor muscle spasms
Current post-void residual volume (PVR) \> 300 mL or catheter dependent bladder drainage
Known poor detrusor muscle function (e.g., Qmax \< 5 mL/sec)
Active bladder, ureteral, or urethral stones or stone passage within the last 3 months
Current poorly controlled diabetes (i.e., hemoglobin A1c ≥ 8%)
Anatomy (e.g., presence of false passage or size of meatus) is not suitable for treatment with the Optilume BPH Catheter System
Obstructive median lobe in the opinion of the investigator

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT06312722) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Benign Prostatic Hyperplasia Treatment Options in Houston, TX

If you're searching for benign prostatic hyperplasia treatment options in Houston, TX, this clinical trial (NCT06312722) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced benign prostatic hyperplasia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all benign prostatic hyperplasia clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Houston, TX

See all pulmonary embolism clinical trials recruiting in Houston — not just this study.

Browse Pulmonary Embolism Trials in Houston →

Browse More Trials by Condition

Pulmonary Embolism TrialsAnkylosing Spondylitis TrialsBenign Prostatic Hyperplasia TrialsInterstitial Cystitis TrialsRetinitis Pigmentosa TrialsRecurrent Pregnancy Loss TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX